Form 4: West Pharmaceutical Services VP & Treasurer Charles Witherspoon Reports Stock Transactions
SEC Form 4 Filing
Charles Witherspoon, VP & Treasurer of West Pharmaceutical Services, reports the exercise of stock options and subsequent sale of shares on October 29, 2024.
Summary
- On October 29, 2024, Charles Witherspoon, VP & Treasurer of West Pharmaceutical Services, exercised stock options to acquire 478 shares of common stock at a price of $173.22 per share.
- Following the exercise of these options, Mr. Witherspoon sold 478 shares at $310.4 and 225 shares at $310.4.
- After these transactions, Mr. Witherspoon directly owns 1,253.141 shares of West Pharmaceutical Services common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reflects routine transactions by an officer exercising vested stock options and selling a portion of the shares. It doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.
Stakeholder Impact
- The transactions may have a minor impact on shareholders as they provide insight into management's actions, but the volume of shares involved is relatively small.
Key Dates
| Date | Description |
|---|---|
| 02/18/2021 | First vesting date of the stock options in four equal annual installments. |
| 10/29/2024 | Date of the reported transactions: exercise of stock options and sale of shares. |
| 10/31/2024 | Date of the signature on the Form 4 filing. |
| 02/18/2030 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.